Leaflet: information for the user
Sirdalud 4 mg tablets
Tizanidina
Read this leaflet carefully before you start taking the medicine, as it contains important information for you.
1. What Sirdalud is and for what it is used
2. What you need to know before starting to take Sirdalud
3. How to take Sirdalud
4. Possible side effects
5. Storage of Sirdalud
6. Contents of the pack and additional information
Sirdalud belongs to a group of medications called muscle relaxants (medications used to relax muscles). It is indicated for the treatment of muscle problems associated with:
chronic hip disease
Do not take Sirdalud
(listed in section 6)
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication and especially:
-If you are a smoker (more than 10 cigarettes per day)
- If you are pregnant or intend to become pregnant, as Sirdalud may be harmful to the fetus.
- Before starting treatment with Sirdalud, your doctor may ask you to perform a pregnancy test to ensure you are not pregnant. During treatment with Sirdalud and at least until a day after stopping, it is recommended to use reliable methods to avoid pregnancy. Consult your doctor about the most suitable methods to use during this time.
- Do not stop treatment abruptly, consult your doctor, as it may cause hypertension and tachycardia, especially if you are taking antihypertensive medications.
- It may cause hypersensitivity reactions, see point 4.
- It may cause visual disturbances and sedation, which may interfere with daily activities.
Taking Sirdalud with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication:
it may intensify the effects of Sirdalud
-amitriptiline (medications used to treat depression)
Sirdalud may intensify the effects of:
Taking Sirdalud with food and drinks
Alcohol may increase the sedative effects of Sirdalud, so it is recommended that you do not drink alcohol while taking this medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Do not take during pregnancy or breastfeeding. It is recommended to perform a pregnancy test before starting treatment with Sirdalud. During treatment with Sirdalud and at least until a day after stopping, it is recommended to use reliable methods to avoid pregnancy. Consult your doctor about the most suitable methods to use during this time.
Driving and operating machinery
Sirdalud may make you feel drowsy, cause dizziness and cold sweats, and see flashes, so you should not drive or operate hazardous machinery while taking this medication.
Important information about some of the components of Sirdalud
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Follow exactly the administration instructions of this medication contained in this leaflet or those indicated by your doctor. If in doubt, ask your doctor or pharmacist.
Remember to take your medication. Your doctor will indicate the duration of your treatment with Sirdalud. Do not stop or prolong it.
Swallow the tablets with a glass of water. The tablets can be split along the notch.
The recommended dose is:
Adults
Half or one tablet (2 mg to 4 mg of tizanidine) three times a day. In severe cases, it may be increased to a maximum daily dose of four tablets (16 mg of tizanidine). Patients with neurological disorders should not take more than nine tablets a day (36 mg of tizanidine).
Patients with any kidney disease
A dose reduction may be necessary if you have any kidney disease, so inform your doctor so that they can adjust the dose accordingly.
Patients with any liver disease
A dose reduction may be necessary if you have any liver disease, so inform your doctor so that they can adjust the dose accordingly.
Use in children
Experience in children is limited, therefore it is not recommended for use in children under 18 years.
Seniors
Experience in seniors is limited. Treatment should be initiated with the lowest dose and your doctor will adjust the dose accordingly.
If you take more Sirdalud than you should
Inform your doctor or pharmacist or go to the nearest hospital. You may need urgent medical attention. Symptoms of overdose are nausea, vomiting, low blood pressure, slowed heart rate, dizziness, drowsiness, pupil constriction, agitation, difficulty breathing, or coma.
In cases of overdose or accidental ingestion, consult the Toxicological Information Service. Phone 91 562 04 20.It is recommended to bring the packaging and the leaflet of the medication to the healthcare professional.
If you forgot to take Sirdalud
Do not take a double dose to compensate for the missed doses. Take the missed dose as soon as possible, unless it is almost time for the next dose, in which case skip the missed dose and take the next dose when it is due.
If you interrupt treatment with Sirdalud
Do not change or stop taking Sirdalud without first consulting your doctor. Your doctor will gradually reduce the dose before completely stopping treatment. This will prevent a worsening and reduce the risk of hypertension (high blood pressure, headache, dizziness) or tachycardia (rapid heart rate).
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Very common(in at least 1 in 10 patients) are:
Nervous system disorders:drowsiness, dizziness
Gastrointestinal disorders:gastrointestinal disturbances, dry mouth
General disorders and administration site conditions:fatigue
Musculoskeletal and connective tissue disorders:muscle weakness
Common(in at least 1 in 100 patients but less than 1 in 10 patients) are:
Mental and behavioural disorders:insomnia, sleep disorders
Vascular disorders:decreased blood pressure.Consult your doctor immediately.
Gastrointestinal disorders: nausea
Investigations:a transient increase in liver enzymes (transaminases) may occur.
Rare(in at least 1 in 1000 patients but less than 1 in 100 patients) are:
Cardiac disorders: bradycardia.
Unknown frequency(cannot be estimated from available data):
Immune system disorders:allergic reactions, severe allergic reactions including difficulty breathing, dizziness (anaphylaxis) and swelling primarily of the face and throat (angioedema).Consult your doctor immediately.
Mental and behavioural disorders:hallucinations, confusion.Consult your doctor immediately
Nervous system disorders: vertigo, speech confusion
Vascular disorders: fainting
Eye disorders:blurred vision
Gastrointestinal disorders:abdominal pain, vomiting
Hepatobiliary disorders:acute hepatitis, hepatic failure.Consult your doctor immediately.
Skin and subcutaneous tissue disorders:inflammation of the skin with rash (dermatitis), redness of the skin (erythema), itching (pruritus) and rash with itching (skin eruption and urticaria)
General disorders:loss of vitality and withdrawal symptoms (hypertension rebound and tachycardia).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging.The expiration date is the last day of the month indicated.
Do not use this medication if you observe that the packaging is damaged or shows signs of manipulation.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Each tablet contains 4 mg of tizanidine (as hydrochloride).
colloidal anhydrous silica.
Appearance of the product and content of the container
Sirdalud 4 mg tablets are presented in the form of a white, circular, scored tablet on one face and with the mark RL on the other. Each container contains 30 tablets.
Holder of the marketing authorization
BEXAL FARMACÉUTICA, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Responsible for manufacturing
Novartis Farmacéutica, S. A.
Gran Vía de les Corts Catalanes, 764
08013 Barcelona, Spain
or
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg, Germany
or
Lek Pharmaceuticals d.d.
Verovskova Ulica 57,
Ljubljana 1526,
Slovenia
Last review date of this leaflet:January 2020
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.